| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hyperlipidemias | D006949 | 73 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Vasculitis | D014657 | 14 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Peripheral Arterial Disease | D058729 | 7 associated lipids |
| Thromboangiitis Obliterans | D013919 | 4 associated lipids |
| Bird Diseases | D001715 | 4 associated lipids |
| Obesity, Morbid | D009767 | 8 associated lipids |
| Cell Transformation, Viral | D002472 | 26 associated lipids |
lauric acid
lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
Cross Reference
Introduction
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with lauric acid?
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with lauric acid
PubChem Associated disorders and diseases
What pathways are associated with lauric acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with lauric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with lauric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with lauric acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with lauric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with lauric acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with lauric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Li H et al. | Phase transition in salt-free catanionic surfactant mixtures induced by temperature. | 2010 | Langmuir | pmid:19810715 |
| Zana R | Partial phase behavior and micellar properties of tetrabutylammonium salts of fatty acids: unusual solubility in water and formation of unexpectedly small micelles. | 2004 | Langmuir | pmid:16459576 |
| Vlachy N et al. | Spontaneous formation of bilayers and vesicles in mixtures of single-chain alkyl carboxylates: effect of pH and aging and cytotoxicity studies. | 2008 | Langmuir | pmid:18712886 |
| Kim JH et al. | Evaporation of sessile droplets of dilute aqueous solutions containing sodium n-alkylates from polymer surfaces: influences of alkyl length and concentration of solute. | 2008 | Langmuir | pmid:18798660 |
| Nelson N et al. | Single molecule dynamics on hydrophobic self-assembled monolayers. | 2012 | Langmuir | pmid:22876990 |
| Roux M et al. | Dynamic lipid lateral segregation driven by lauryl cyclodextrin interactions at the membrane surface. | 2013 | Langmuir | pmid:23409976 |
| Totland C et al. | Composition and structural transitions of polyelectrolyte-surfactant complexes in the presence of fatty acid studied by NMR and cryo-SEM. | 2015 | Langmuir | pmid:25590530 |
| Sagis LM et al. | Highly stable foams from block oligomers synthesized by enzymatic reactions. | 2008 | Langmuir | pmid:18081334 |
| Steinmiller EM and Choi KS | Anodic construction of lamellar structured ZnO films using basic media via interfacial surfactant templating. | 2007 | Langmuir | pmid:17973505 |
| Hidalgo Baltasar E et al. | Role of water structure on the high pressure micellization and phase transformations of sodium dodecanoate aqueous solutions. | 2014 | Langmuir | pmid:24903603 |
| Chernyshova IV et al. | Adsorption of fatty acids on iron (hydr)oxides from aqueous solutions. | 2011 | Langmuir | pmid:21711036 |
| King DT et al. | Using molecular dynamics to study liquid phase behavior: simulations of the ternary sodium laurate/sodium oleate/water system. | 2011 | Langmuir | pmid:21838286 |
| Li H et al. | Reverse vesicles from a salt-free catanionic surfactant system: a confocal fluorescence microscopy study. | 2010 | Langmuir | pmid:20822115 |
| De Lisi R et al. | Heat capacity of transfer of (Ethylene oxide)13-(propylene oxide)30-(ethylene oxide)13 from water to the aqueous anionic surfactant solutions at 298 K. A quantitative treatment. | 2004 | Langmuir | pmid:15518478 |
| Mahiuddin S et al. | Catanionic micelles as a model to mimic biological membranes in the presence of anesthetic alcohols. | 2009 | Langmuir | pmid:19856990 |
| Nicolaas L et al. | Patellofemoral evaluation with magnetic resonance imaging in 51 knees of asymptomatic subjects. | 2011 | Knee Surg Sports Traumatol Arthrosc | pmid:21533540 |
| Gross V et al. | Inhibition of pressure natriuresis in mice lacking the AT2 receptor. | 2000 | Kidney Int. | pmid:10620200 |
| Ghiggeri GM et al. | Characterization of cationic albumin in minimal change nephropathy. | 1987 | Kidney Int. | pmid:3430951 |
| Shirakura S et al. | Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs. | 1994 | Jpn. J. Pharmacol. | pmid:7967232 |
| Hasumura S et al. | Effects of starvation on microsomal cytochrome P-450 and laurate-omega-hydroxylation of rat kidney and liver. | 1983 | Jpn. J. Pharmacol. | pmid:6645119 |
| Miura Y et al. | An analysis of the fatty acid composition of total lipids from mycoplasmas. | 1978 | Jpn. J. Exp. Med. | pmid:750678 |
| Sigalet DL et al. | Determination of the route of medium-chain and long-chain fatty acid absorption by direct measurement in the rat. | 1997 Sep-Oct | JPEN J Parenter Enteral Nutr | pmid:9323689 |
| Yoon JW and Hovde CJ | All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection. | 2008 | J. Vet. Sci. | pmid:18716441 |
| Mann RS and Kaufman PE | Colonization of Lutzomyia shannoni (Diptera: Psychodidae) utilizing an artificial blood feeding technique. | 2010 | J. Vector Ecol. | pmid:21175933 |
| Kong X et al. | High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats. | 2013 | J. Vasc. Surg. | pmid:23069071 |
| Garfinkel M et al. | Insulinotropic potency of lauric acid: a metabolic rationale for medium chain fatty acids (MCF) in TPN formulation. | 1992 | J. Surg. Res. | pmid:1593871 |
| Raynaud JP et al. | Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. | 2002 | J. Steroid Biochem. Mol. Biol. | pmid:12477490 |
| Coimbra MC and Jorge N | Fatty acids and bioactive compounds of the pulps and kernels of Brazilian palm species, guariroba (Syagrus oleraces), jerivá (Syagrus romanzoffiana) and macaúba (Acrocomia aculeata). | 2012 | J. Sci. Food Agric. | pmid:21922463 |
| Blum JJ | Effects of osmotic pressure on the oxidative metabolism of Leishmania major promastigotes. | 1991 May-Jun | J. Protozool. | pmid:1679134 |
| Wołkow PP and Korbut R | Pharmacology at the Jagiellonian University in Kracow, short review of contribution to global science and cardiovascular research through 400 years of history. | 2006 | J. Physiol. Pharmacol. | pmid:16766803 |
| Sidhu SS et al. | Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag. | 2000 | J. Physiol. (Lond.) | pmid:11018115 |
| Feltrin KL et al. | Effects of lauric acid on upper gut motility, plasma cholecystokinin and peptide YY, and energy intake are load, but not concentration, dependent in humans. | 2007 | J. Physiol. (Lond.) | pmid:17331985 |
| Benson RS et al. | Fatty acid signalling in a mouse enteroendocrine cell line involves fatty acid aggregates rather than free fatty acids. | 2002 | J. Physiol. (Lond.) | pmid:11773321 |
| Kazmi S et al. | Calcium mobilisation and CCK secretion induced by modified fatty acids and latex microspheres reveal dual receptor mechanisms for lipid stimulation of STC-1 cells. | 2003 | J. Physiol. (Lond.) | pmid:14555726 |
| Inami Y et al. | Prevention of topical surfactant-induced itch-related responses by chlorogenic acid through the inhibition of increased histamine production in the epidermis. | 2013 | J. Pharmacol. Sci. | pmid:23449492 |
| Lindmark T et al. | Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9435199 |
| Cresteil T et al. | Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. | 1986 | J. Pharmacol. Exp. Ther. | pmid:3941398 |
| Inami Y et al. | Topical surfactant-induced pruritus: involvement of histamine released from epidermal keratinocytes. | 2013 | J. Pharmacol. Exp. Ther. | pmid:23220712 |
| Wang JS et al. | Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues. | 2004 | J. Pharmacol. Exp. Ther. | pmid:15269250 |
| Coyne CB et al. | Acute mechanism of medium chain fatty acid-induced enhancement of airway epithelial permeability. | 2003 | J. Pharmacol. Exp. Ther. | pmid:12606647 |
| Imaoka S et al. | Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase. | 1993 | J. Pharmacol. Exp. Ther. | pmid:8246128 |
| Fang X et al. | Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15798002 |
| Xu F et al. | Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. | 2004 | J. Pharmacol. Exp. Ther. | pmid:14634044 |
| Bumpus NN and Johnson EF | 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent. | 2011 | J. Pharmacol. Exp. Ther. | pmid:21896918 |
| Mishima M et al. | Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I. | 1989 | J. Pharmacobio-dyn. | pmid:2656985 |
| Nakamura J et al. | Effect of straight chain fatty acids on seizures induced by picrotoxin and pentylenetetrazole in mice. | 1990 | J. Pharmacobio-dyn. | pmid:2341972 |
| Ogiso T et al. | Enhancement by fatty acids of the rectal absorption of propranolol: in vitro evaluation in the rat. | 1991 | J. Pharmacobio-dyn. | pmid:1802986 |
| CARLESS JE and NIXON JR | The oxidation of solubilised and emulsified oils. Part III. The oxidation of methyl linoleate in potassium laurate and cetomacrogol dispersions. | 1960 | J. Pharm. Pharmacol. | pmid:13807717 |
| CARLESS JE and NIXON JR | The oxidation of solubilised and emulsified oils. Part II. Solubility of benzaldehyde, cyclohexene and methyl linoleate in potassium laurate and cetomacrogol solutions. | 1960 | J. Pharm. Pharmacol. | pmid:13807716 |
| Adachi H et al. | Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101. | 1992 | J. Pharm. Pharmacol. | pmid:1361553 |